Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-12-10

FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for Albuterol Sulfate HFA inhalation aerosol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albuterol Sulfate HFA Inhalation Aerosol (albuterol sulfate)

Snippet

SUPPL AP for ALBUTEROL SULFATE HFA (ALBUTEROL SULFATE)